Interferon regulatory factor 4 (IRF4) rearrangement is commonly detected in patients with a
range of lymphoproliferative malignancies, including myelomas, large B cell lymphomas and …

Mycosis fungoides (MF) is an indolent cutaneous T-cell lymphoma and may transform into
large cell lymphoma in the disease course. The incidence of MF in Taiwan is lower as …

Rearrangements involving interferon regulatory factor 4 (IRF4) gene has been recently
described in a subtype of diffuse large B-cell lymphoma (DLBCL). They occur in a typical …

Classified as a provisional entity in the 4th edition of the World Health Organization (WHO)
classification of hematolymphoid tumors, IRF4-Large B cell lymphoma (LBCL) was recently …

Low-grade B-cell lymphoma with immunoglobulin (IG) and interferon regulatory factor 4
(IRF4) gene rearrangement is extremely rare, with only 4 cases being previously reported. In …

Background Large B-cell lymphoma with IRF4 rearrangement (LBCL-IRF4) is a rare subtype
of large B-cell lymphoma characterized by strong and uniform IRF4/MUM1 expression …

Indolent B-cell lymphomas show relatively good prognosis, cause few symptoms such as
weight loss and fever, and exhibit a chronic course and slow progression. Histologically …

Введение. Крупноклеточная В-клеточная лимфома с перестройкой IRF4-редкая
патология, возникает у детей и молодых взрослых, протекает с вовлечением …

Introduction. Large B-cell lymphoma with IRF4 rearrangement is rare disease, recently
described in WHO 2017, arising in children and young adults, presenting with enlarged …

Objective To identify the clinicopathological features and prognosis of large B-cell
lymphoma (LBCL) with interferon regulation factor 4 (IRF4) rearrangement. Methods We …